References
Terkeltaub RA (2003) Clinical practice. Gout N Engl J Med 349:1647–1655
Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, Schuhmacher HR Jr (2001) Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 28:577–580
Groff GD, Franck WA, Raddatz DA (1990) Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 19:329–336
Yu TF, Gutman AB (1961) Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med 55:179–192
Di Giovine FS, Malawista SE, Thornton E, Duff GW (1991) Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 87:1375–1381
Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, Mariette X (2003) Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a follow up report of tolerability and efficacy. Arthritis Rheum 48:2019–1024
Tausche AK, Richter K, Grässler A, Hänsel S, Roch B, Schröder HE (2004) Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor as a new therapeutic option. Ann Rheum Dis 63:1351–1352
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fiehn, C., Zeier, M. Successful treatment of chronic tophaceous gout with infliximab (Remicade). Rheumatol Int 26, 274–276 (2006). https://doi.org/10.1007/s00296-005-0617-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-005-0617-7